[Federal Register Volume 61, Number 117 (Monday, June 17, 1996)]
[Page 30615]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-15307]


[Docket No. C-3645]

Johnson & Johnson; Prohibited Trade Practices, and Affirmative 
Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent order.


SUMMARY: In settlement of alleged violations of federal law prohibiting 
unfair or deceptive acts or practices and unfair methods of 
competition, this consent order requires, among other things, a New 
Jersey-based manufacturer of health care products to divest, within 12 
months, the Cordis Neuroscience Business to a Commission-approved 
acquirer. If the transaction is not complete as required, then the 
Commission may appoint a trustee.

DATES: Complaint and Order issued March 19, 1996.\1\

    \1\ Copies of the Complaint and the Decision and Order are 
available from the Commission's Public Reference Branch, H-130, 6th 
Street & Pennsylvania Avenue, NW., Washington, DC 20580.

FOR FURTHER INFORMATION CONTACT: Ann Malester, FTC/S-2308, Washington, 
DC 20580. (202) 326-2682.

SUPPLEMENTARY INFORMATION: On Tuesday, January 2, 1996, there was 
published in the Federal Register, 61 FR 66, a proposed consent 
agreement with analysis In the Matter of Johnson & Johnson, for the 
purpose of soliciting public comment. Interested parties were given 
sixty (60) days in which to submit comments, suggestions or objections 
regarding the proposed form of the order.
    No comments having been received, the Commission has ordered the 
issuance of the complaint in the form contemplated by the agreement, 
made its jurisdictional findings and entered an order to divest, as set 
forth in the proposed consent agreement, in disposition of this 

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret or apply sec. 5, 38 
Stat. 719, as amended; sec. 7, 38 Stat. 731, as amended; 15 U.S.C. 
45, 18)
Donald S. Clark,
[FR Doc. 96-15307 Filed 6-14-96; 8:45 am]